ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 199

Joint, Hand and Feet Swelling As a Presenting Symptom of Hereditary Angioedema

Maria J. Gutierrez1 and Timothy J. Craig2, 1Department of Pediatrics, Division of Pediatric Rheumatology. Department of Medicine, Section of Allergy and Immunology, Penn State College of Medicine Milton S. Hershey Medical Center, Hershey, PA, 2Department of Medicine. Division of Pulmonary, Allergy and Critical Care Medicine, Penn State College of Medicine Milton S. Hershey Medical Cente, Hershey, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: diagnosis

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases: Periodic Fever Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose: Hereditary Angioedema (HAE) is a rare disorder caused by deficiency or impaired function of C1 esterase inhibitor.  Early and accurate diagnosis of HAE is important to initiate appropriate therapy and avoid potentially fatal outcomes. However, HAE symptoms can mimic other conditions potentially leading to incorrect diagnosis and delay in treatment. Our purpose was to investigate the proportion of hand, feet and joint swelling as presenting signs of hereditary angioedema across different countries. 

Methods: A web-based survey was conducted among physicians who treated HAE patients within their practice in over 30 countries in North and Latin America, Europe, Asia, Africa and Oceania. Physicians voluntarily accessed and completed the internet-based survey between November 2010 and February 2011. 

Results: A total of 201 international physicians who treated HAE patients completed the survey.  Most patients treated by surveyed physicians were under 35 years-old (67%) and symptoms had first presented during childhood or adolescence in 77% of all cases. Among respondents there was widespread consensus about delay between the first HAE attack and diagnosis. Overall, only 14% of treated patients had been diagnosed within the first year and in 48% of cases there was a reported delay of 4 or more years. The patient’s most common complaint that prompted evaluation for HAE was facial swelling.  Nonetheless, hand, feet or joint swelling were listed as one of the two most common symptoms at onset by 40% of physicians. Interestingly, hand, foot and joint swelling were also ranked among the three most problematic symptoms during attacks by 35% of physicians surveyed. 

Conclusion: HAE is a rare condition that usually presents during the first two decades of life and may present with hand, feet and joint swelling as main symptom. In addition, an important proportion of surveyed physicians thought that this is one of the most problematic symptoms of patients with HAE. Accordingly, HAE should be included in the differential diagnosis of certain types of joint and extremity edema, and thus, increased awareness of the pediatric rheumatology community could lead to a decrease in the morbidity and mortality of this condition.

 


Disclosure:

M. J. Gutierrez,
None;

T. J. Craig,

Dyax, Shire, Viropharma, Pharming, CSL Behring,

2,

CSL Behring,

5,

Dyax, Shire, Viropharma, CSL Behring,

8.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-hand-and-feet-swelling-as-a-presenting-symptom-of-hereditary-angioedema/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology